Skip to main content
TipRanks
Go Ultimate75% OFF

Kevin Quinlan Insider Profile

4 Followers

Kevin Quinlan, CFO at Anika Therapeutics, holds 27.11K shares in Anika Therapeutics (Ticker: ANIK), holds 2.50K shares in Pressure Biosciences (Ticker: PBIO).

Kevin Quinlan's Trading History

ANIK
Anika Therapeutics
Mar 28, 2013CFOUninformative Buy206.52K$365.20K
PBIO
Pressure Biosciences
―Director―$250.00

You May Also Like

Kevin Quinlan insider profile FAQ

What is the percentage of profitable transactions made by Kevin Quinlan?
The percentage of profitable transactions made by Kevin Quinlan is 25%.
What is the average return per transaction made by Kevin Quinlan?
The average return per transaction made by Kevin Quinlan is -85.40%.
What stocks does Kevin Quinlan hold?
Kevin Quinlan holds: ANIK, PBIO stocks.
What was Kevin Quinlan’s latest transaction?
Kevin Quinlan’s latest transaction was an Uninformative Buy of $206.52K.
What was Kevin Quinlan's most profitable transaction?
Kevin Quinlan’s most profitable transaction was an Informative Buy of ANIK stock on August 24, 2010. The return on the trade was 19.30%.
What is Kevin Quinlan's role in Anika Therapeutics?
Kevin Quinlan's role in Anika Therapeutics is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.